Back

Chondrocalcinosis and the haemochromatosis linked HFE C282Y homozygous variant in the UK Biobank

Banfield, L. R.; Knapp, K. M.; Pilling, L. C.; Melzer, D.; Atkins, J. L.

2025-03-19 epidemiology
10.1101/2025.03.18.25324165 medRxiv
Show abstract

BackgroundC282Y genetic homozygosity is the main cause of the iron-overload disorder haemochromatosis. Musculoskeletal pain and arthropathy are common in haemochromatosis, but less is known about chondrocalcinosis (cartilage calcification) with the C282Y variant, especially in the community. We assessed knee chondrocalcinosis in iDXA (dual-energy X-ray absorptiometer) images from UK Biobank volunteers by HFE genotype. MethodsData were from 236 European genetic ancestry C282Y homozygotes and 236 age, sex, and BMI-matched controls with no C282Y alleles (48-80 years, mean 64.6, SD {+/-}7.6). 435 of 472 participants had relevant left and right knee iDXA imaging. Evidence of chondrocalcinosis was assessed by an experienced reporting radiographer blind to genotype to ensure unbiased and objective evaluation. Logistic regression models were age, sex and BMI matched. ResultsKnee chondrocalcinosis was present in 15.9% (14/88) of C282Y homozygous males and <5.9% (<5/84) of males without variants (OR=7.76, 95% CI: 1.71-35.25, p=0.008). 57.1% (8/14) of the male homozygotes with knee chondrocalcinosis reported knee pain during the previous three months, but <28.6% also had a haemochromatosis diagnosis. In females, 6.0% (8/134) of C282Y homozygotes had knee chondrocalcinosis, vs <3.9% (<5/129) without variants. However, the odds of chondrocalcinosis were not significantly higher in C282Y homozygotes (OR=1.98, 95% CI: 0.58-6.76, p=0.273), therefore a larger sample size may be required to detect a smaller effect in female homozygotes. ConclusionIn this community genotyped sample, male C282Y homozygotes had a markedly increased odds of knee chondrocalcinosis. Evaluation of serum ferritin levels to identify possible haemochromatosis may be justified in knee chondrocalcinosis management.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Rheumatology
21 papers in training set
Top 0.1%
38.4%
2
Journal of Bone and Mineral Research
32 papers in training set
Top 0.1%
3.6%
3
PLOS ONE
4510 papers in training set
Top 38%
3.6%
4
RMD Open
13 papers in training set
Top 0.1%
1.9%
5
The Journals of Gerontology: Series A
25 papers in training set
Top 0.5%
1.7%
6
Trials
25 papers in training set
Top 0.8%
1.7%
50% of probability mass above
7
Nature Communications
4913 papers in training set
Top 51%
1.7%
8
Journal of Internal Medicine
12 papers in training set
Top 0.2%
1.7%
9
European Journal of Epidemiology
40 papers in training set
Top 0.4%
1.5%
10
International Journal of Epidemiology
74 papers in training set
Top 1%
1.5%
11
BMJ Open
554 papers in training set
Top 10%
1.5%
12
Osteoarthritis and Cartilage
30 papers in training set
Top 0.3%
1.4%
13
Journal of Medical Genetics
28 papers in training set
Top 0.3%
1.4%
14
Thorax
32 papers in training set
Top 0.5%
1.4%
15
British Journal of Haematology
15 papers in training set
Top 0.3%
1.2%
16
Human Mutation
29 papers in training set
Top 0.5%
1.2%
17
Wellcome Open Research
57 papers in training set
Top 1%
1.2%
18
Scientific Reports
3102 papers in training set
Top 66%
1.2%
19
Frontiers in Neurology
91 papers in training set
Top 4%
1.2%
20
Frontiers in Medicine
113 papers in training set
Top 5%
1.2%
21
JBMR Plus
16 papers in training set
Top 0.2%
1.2%
22
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
23
European Respiratory Journal
54 papers in training set
Top 2%
0.8%
24
Kidney International
25 papers in training set
Top 0.4%
0.7%
25
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 1%
0.7%
26
PLOS Genetics
756 papers in training set
Top 15%
0.7%
27
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.8%
0.7%
28
npj Genomic Medicine
33 papers in training set
Top 1%
0.7%
29
Age and Ageing
27 papers in training set
Top 0.5%
0.5%
30
PLOS Medicine
98 papers in training set
Top 6%
0.5%